What is Isopure?
Isopure Corp. stands as a prominent entity in the manufacturing and installation of advanced water treatment systems, with a specialized focus on hemodialysis centers. Leveraging cutting-edge technologies and bespoke solutions, Isopure ensures its offerings meet stringent CMS AAMI standards. The company addresses the critical operational challenges faced by dialysis clinics, providing indispensable support for their infrastructure. Beyond product provision, Isopure extends its services to include comprehensive technical support and training, empowering clients to optimize their water treatment processes and maintain regulatory compliance.
How much funding has Isopure raised?
Isopure has raised a total of $954K across 2 funding rounds:
Debt
$350K
Debt
$604K
Debt (2020): $350K with participation from PPP
Debt (2021): $604K led by PPP
Key Investors in Isopure
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Isopure?
The recent major strategic investment signals a pivotal moment for Isopure, likely enabling accelerated expansion of its technological capabilities and market reach. With a foundation built on enterprise-level funding, the company is well-positioned to further innovate its water treatment solutions for the demanding hemodialysis sector. Future growth may involve scaling production, enhancing service offerings, and potentially exploring new geographical markets or related healthcare infrastructure segments. This capital infusion is expected to solidify Isopure's leadership and drive further advancements in patient care through superior water quality.
See full Isopure company page
